[HTML][HTML] The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review

S Chakka, RL Krain, JSS Concha… - Annals of …, 2021 - ncbi.nlm.nih.gov
Cutaneous lupus erythematosus (CLE) can present with or without features of systemic
lupus erythematosus (SLE), with estimates of the incidence of isolated skin disease almost …

[HTML][HTML] Cutaneous lupus erythematosus and dermatomyositis: Utilizing assessment tools for treatment efficacy

BF Chong, V Werth - Journal of Investigative Dermatology, 2022 - Elsevier
There have been important developments in defining cutaneous lupus erythematosus and
dermatomyositis. The skin manifestations of these two diseases have a profound impact on …

[HTML][HTML] Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise

SP Ardoin, RP Daly, L Merzoug, K Tse, K Ardalan… - Pediatric …, 2019 - Springer
Background Childhood-onset systemic erythematosus lupus (cSLE) is characterized by
more severe disease, widespread organ involvement and higher mortality compared to adult …

[PDF][PDF] S2k guideline: Diagnosis and management of cutaneous lupus erythematosus–Part 1: Classification, diagnosis, prevention, activity scores

M Worm, M Zidane, L Eisert… - JDDG: Journal der …, 2021 - refubium.fu-berlin.de
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1:
Classification, diagnosis, prevention, act Page 1 1236 © 2021 The Authors. Journal der …

[HTML][HTML] Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A report from the 4th International Conference on Cutaneous Lupus Erythematosus An …

JSS Concha, A Patsatsi… - The Journal of …, 2019 - ncbi.nlm.nih.gov
Consulting: Celgene, Medimmune, Resolve, Neovcs, Genetech, Idera, Octapharma, BSL
Behring, Janssen, Lilly, Pfizer, Biogen, BMS, Gilead, Amgen, Medscape, Nektar, Incyte, EMD …

[HTML][HTML] Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures

RG Gaffney, VP Werth, JF Merola - Frontiers in Medicine, 2022 - frontiersin.org
Cutaneous lupus erythematosus (CLE) is an autoimmune skin disease that can occur with or
without systemic lupus erythematosus (SLE). This potentially disfiguring disease can have …

[HTML][HTML] Outcome scores in pediatric rheumatology

G Giancane, S Rosina, A Consolaro… - Current Rheumatology …, 2021 - Springer
Abstract Purpose of Review Providing a summary of the latest research on outcome
measures in juvenile idiopathic arthritis, childhood-onset systemic lupus erythematosus, and …

Update on outcome measures for pediatric systemic lupus erythematosus

S Rosina, J Tibaldi, M Mazzoni, C Bava… - Arthritis Care & …, 2020 - Wiley Online Library
Systemic lupus erythematosus (SLE) is a chronic autoimmune, multisystem inflammatory
disease of unknown etiology that is characterized by protean clinical manifestations …

S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes-Teil 1: Klassifikation, Diagnostik, Prävention und Aktivitätsscores

M Worm, M Zidane, L Eisert… - … = Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes - Teil 1:
Klassifikation, Diagnostik, Prävention und Aktivitätsscores S2k-Leitlinie zur Diagnostik und …

[HTML][HTML] Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis

VP Werth, AD Askanase, IE Lundberg - International Journal of Women's …, 2021 - Elsevier
There have been a number of advances in the clinical and translational understanding of
cutaneous lupus and dermatomyositis, which both disproportionately affect women. These …